10X Genomics Inc (NASDAQ:TXG)
| 195.92 BATS BZX Real-Time Price As of 2:06pm ET |  -2.84 / -1.43%Today’s Change | 83.37 Today|||52-Week Range 203.64 | +38.36% Year-to-Date |
Latest TXG News | Press Releases
No recent news for 10X Genomics Inc.
Today’s Trading
| Previous close | 198.76 |
| Today’s open | 198.62 |
| Day’s range | 194.04 - 200.45 |
| Volume | 25,965 |
| Average volume (3 months) | 820,139 |
| Market cap | $21.3B |
Data as of 2:06pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | -1,552.45% |
| Earnings growth (this year) | +87.26% |
| Earnings growth (next 5 years) | -109.13% |
| Revenue growth (last year) | +21.53% |
| P/E ratio | NM |
| Price/Sales | 47.93 |
| Price/Book | 28.42 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 17, 2021 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $298.8M |
| Annual profit (last year) | -$542.7M |
| Net profit margin | -181.61% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
